Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma.
Saved in:
| Title: | Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma. |
|---|---|
| Authors: | Matsumura‐Kimoto, Yayoi1 (AUTHOR), Tsukamoto, Taku1 (AUTHOR), Shimura, Yuji1 (AUTHOR), Chinen, Yoshiaki1 (AUTHOR), Tanba, Kazuna1 (AUTHOR), Kuwahara‐Ota, Saeko1 (AUTHOR), Fujibayashi, Yuto1 (AUTHOR), Nishiyama, Daichi1 (AUTHOR), Isa, Reiko1 (AUTHOR), Yamaguchi, Junko1 (AUTHOR), Kawaji‐Kanayama, Yuka1 (AUTHOR), Kobayashi, Tsutomu1 (AUTHOR), Horiike, Shigeo1 (AUTHOR), Taniwaki, Masafumi1,2 (AUTHOR), Kuroda, Junya1 (AUTHOR) junkuro@koto.kpu-m.ac.jp |
| Source: | Cancer Medicine. Jul2020, Vol. 9 Issue 14, p5185-5199. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
